Contrast Media & Molecular Imaging

Cover image for Contrast Media & Molecular Imaging

March/April 2006

Volume 1, Issue 2

Pages 49–100

    1. MRI; Liver agents

    2. CMR 2005: 1.02: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver (page 52)

      S. Hirohashi, N. Tsuda, T. Tsuji and N. Katoh

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.3

    3. CMR 2005: 1.03: Analysis of hepatic uptake of anionic magnetic nanoparticles (pages 52–53)

      E. Lee, F. Gazeau, O. Beuf, J-C. Bacri, A. Briguet, M. Janier and C. Billotey

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.4

    4. CMR 2005: 1.04: Comparison of VSOP-C184, gadopentetate dimeglumine and ferucarbotran in T1-weighted dynamic and T2-weighted late MRI of focal liver lesions in rabbits (page 53)

      J. Schnorr, S. Wagner, C. Abramjuk, T. Schink, E. Schellenberger, H. Pilgrimm, B. Hamm and M. Taupitz

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.5

    5. MRI; Iron oxide particles

    6. CMR 2005: 2.04: MRI of cerebral ischemia with ultra-small superparamagnetic particles of iron oxide in mice (pages 55–56)

      M. Wiart, T.H. Cho, J.B. Pialat, O. Beuf, J.B. Langlois, N. Nighoghossian and Y. Berthezene

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.11

    7. CMR 2005: 2.05: Use of magnetic nanoparticles as intracellular agents for hyperthermia (pages 56–57)

      J.P. Fortin, C. Wilhelm, F. Gazeau, J. Servais, D. Talbot, C. Ménager and J.C. Bacri

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.12

    8. CMR 2005: 2.06: Ferumoxtran-10 enhanced MR imaging in detection of metastases outside the normal surgical area in prostate cancer (page 57)

      J.O. Barentsz, R. Heesakkers, A. Hovels, F. Witjes, B. Knipscheer, P. Mulders and C. Hulsbergen

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.13

    9. Targeting; Tumor

      CMR 2005: 3.01: MRI tumor characterization using Gd–GlyMe–DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent (page 57)

      R. Brasch, H.-J. Raatschen, Z. Boyd, D. Shames, M. Zierhut, R. Swain, B. Misselwitz, H. Weinmann and M. Wendland

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.14

    10. CMR 2005: 3.03: New RGD peptide-based molecular imaging agents for detection of angiogenesis (page 58)

      B. Indrevoll, G.M. Kindberg, H. Karlsen, M. Mendizabal, M. Morrison, A. Healey and A. Cuthbertson

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.16

    11. CMR 2005: 3.05: In vivo follow-up of Gd-labeled liposome concentrations in rats bearing a glioma: a comparative study (page 59)

      G. Le Duc, S. Corde, P. Régnard, T. Brochard, C. Nemoz, A. Werner, J. Nieland and H. Haas

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.18

    12. CMR 2005: 3.06: PEGylated and fluorescent superparamagnetic liposomes provide a promising tool for combining in vivo imaging and therapy (pages 59–60)

      S. Lesieur, M.S. Martina, V. Plassat, J.P. Fortin, C. Rivière, G. Barratt, C. Ménager, O. Clément, C. Wilhelm, F. Gazeau, Y. Tomita and J. Seylaz

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.19

    13. CMR 2005: 3.07: High-Z compounds for synchrotron stereotactic radiotherapy: developments and perspectives (page 60)

      F. Estève, J.F. Adam, M.C. Biston, A. Joubert, S. Corde, C. Boudou, J. Rousseau, J. Gastaldo, Z. Bencokova, J. Rousseau, A.M. Charvet, N. Foray, J.F. Le Bas, J. Balosso and H. Elleaume

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.20

    14. CMR 2005: 3.08: Preliminary imaging results with NM404 in lung cancer patients (pages 60–61)

      J. P. Weichert, M. A. Longino, S. Perlman, A. Pinchuk and J.H. Schiller

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.21

    15. CMR 2005: 3.09: Preclinical efficacy of 177Lu-AMBA, a radiotherapeutic targeting the GRP receptor (page 61)

      L.E. Lantry, M.E. Maddalena, J.S. Fox, J. Chen, S.M. Eaton, N.J. Bogdan, R. Thomas, E. Cappelletti, L. Lattuada, H. Nguyen, K.E. Linder, R.E. Swenson, M.F. Tweedle and A.D. Nunn

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.22

    16. Targeting; Vascular-inflammation

    17. CMR 2005: 4.02: Targeted MR nanoparticles for local anti-restenotic therapy following angioplasty (page 62)

      T. Cyrus, S.D. Caruthers, T.D. Harris, V. Glattauer, J. Werkmeister, J. Ramshaw, S.A. Wickline and G.M. Lanza

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.24

    18. CMR 2005: 4.03: A new contrast agent for magnetic resonance imaging of the vascular walls (page 62)

      F. Chaubet, E. Canet-Soulas, Linda Chaabane, C. Zahir, I. Brigger, C. Corot and D. Letourneur

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.25

    19. Session 4: Targeting; Vascular-inflammation

      CMR 2005: 4.06: Proof-of-concept of folate receptor-targeted MRI of antigen-induced arthritis (page 63)

      H.E. Daldrup-Link, O. Saborowski, G.H. Simon, M. Wendland and C. Corot

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.28

    20. Iodinated agents; Tolerance

    21. MR agents; Clinical applications

    22. CMR 2005: 6.03: The efficacy of MultiHance (gadobenate dimeglumine or Gd–BOPTA) at 1.5 and 3 T in a rat brain glioma model (pages 68–69)

      V.M. Runge, J. Biswas, B.J. Wintersperger, S.S. Baumannn, C.B. Jackson, C.U. Herborn and T. Patel

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.36

    23. CMR 2005: 6.04: Blood-pool contrast medium (Vistarem) discriminates acutely infarcted from scarred myocardium on late enhancement (page 69)

      M. Saeed, O. Weber, R. Lee, L. Do, P. Robert, C. Corot, D. Saloner and C.B. Higgins

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.37

    24. CMR 2005: 6.05: Phase I clinical trial of gadomer (page 69)

      B. Tombach, J. Schneider, P. Reimer, M. Mahler, W. Ebert, K. Shamsi and W. Heindel

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.38

    25. Molecular imaging: Optical-perfusion

      CMR 2005: 7.01: Planar and tomographic imaging of expression in human tumor xenografts (page 70)

      A. von Wallbrunn, C. Höltke, M. Zühlsdorf, W. Heindel, M. Schäfers and C. Bremer

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.39

    26. CMR 2005: 7.02: Exploring microvessels using intravital fluorescence microscopy: role of molecular weight of agents (page 70)

      L.S. Fournier, N. Faye, O. Clément, M.S. Martina, N. Siauve and C.A. Cuénod

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.40

    27. CMR 2005: 7.05: Contrast-enhanced ultrasound and CT for quantifying response to anti-angiogenic therapy in a rat tumor model (pages 71–72)

      R. Pollard, A.R. Sadlowski, E.R. Wisner, S. Bloch, S. Griffey, D. Shalinsky and K.W. Ferrara

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.43

    28. CMR 2005: 7.07: Simultaneous placental perfusion and permeability assessment by dual echo contrast-enhanced MRI in mice (pages 72–73)

      C.A. Cuenod, F. Taillieu, L.J. Salomon, N. Siauve, O. Clément, D. Balvay, C. Vayssettes and Y. Ville

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.45

    29. US agents

      CMR 2005: 8.01: Dextran-coated PFOB emulsion: a potential targeted US contrast agent (page 73)

      Y. Zheng, D. Vera, C. Hoh and R. Mattrey

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.46

    30. CMR 2005: 8.02: Fibrin-directed nanoparticles for combined imaging and local thrombolytic therapy (page 73)

      J.N. Marsh, M.S. Hughes, P.J. Gaffney, M.J. Scott, S.A. Wickline and G.M. Lanza

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.47

    31. CMR 2005: 8.03: Targeted ultrasound contrast agents for molecular imaging in high-shear flow (page 74)

      A.L. Klibanov, J.J. Rychak, W.C. Yang, B. Li, S. Acton, J.R. Lindner, K.F. Ley and S. Kaul

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.48

    32. CMR 2005: 8.04: Shell-rupture detection for single ultrasound contrast microbubbles (page 74)

      A.Y. Ammi, R.O. Cleveland, J. Mamou, G.I. Wang, O. Lucidarme, S.L. Bridal and W.D. O'Brien Jr

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.49

    33. CMR 2005: 8.05: Effects of high MI exposure during contrast echocardiography with SonoVue™ in the dog (pages 74–75)

      X. Fouillet, T. Messager, A. Broillet, S. Milano, D. Ravelo and M. Schneider

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.50

    34. CMR 2005: 8.07: Real-time assessment and off-line quantification of flow dynamics in intracranial aneurysms using intra-operative contrast-specified ultrasound (pages 75–76)

      T. Hölscher, W.G. Wilkening, S. Singel, H. Sang U, S. Hardin, J. Rodriguez-Rodriguez, R.F. Mattrey and J.C. Lasheras

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.52

    35. MRI; Cellular imaging

      CMR 2005: 9.01: Instant magnetic labeling of stem cells using magnetoelectroporation (page 76)

      P. Walczak, D. Kedziorek, A.A. Gilad, S. Lin and J.W.M. Bulte

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.53

    36. CMR 2005: 9.02: Detection of single cells by high-field MRI (page 76)

      F. Gazeau, P. Smirnov, J.P. Fortin, C. Wilhelm and B. Gillet

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.54

    37. CMR 2005: 9.04: In vivo single-cell MRI of lymphocytes in tumors at 1.5 T using a superconducting surface coil (pages 77–78)

      P. Smirnov, M. Poirier-Quinot, E. Lavergne, F. Gazeau, J.-C. Ginefri, B. Combadière, O. Clement and L. Darrasse

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.56

    38. CMR 2005: 9.05: Magnetic labeling and in vivo tracking of embryonic stem cells: efficacy, biological effects, high-field detection limits and long-term results (page 78)

      K. Sieland, A. Stroh, C. Faber, T. Neuberger, K. Weir, S. Mueller, P. Lorenz, T. Grune, P. Jakob, M. Taupitz, H. Pilgrimm and C. Zimmer

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.57

    39. CMR 2005: 9.06: Iron oxide nanoparticles as a cell labeling contrast agent for non-invasive long-term cell therapy monitoring by MRI: an abdominal aortic aneurysm model (pages 78–79)

      C. Rivière, J.F. Deux, J. Dai, F. Gazeau, P. Méric, J. Roger, F. Boudghène, E. Allaire and D. Letourneur

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.58

    40. CMR 2005: 9.07: In vivo MR tracking of magnetically labeled dendritic cells: first clinical experience (page 79)

      J. Barentsz, P. Verdijk, I. de Vries, W. Lesterhuis, T. Scheenen, O. Boerman, W. Oyen, G. Adema, J. van Krieken, J. Bulte, C. Punt, A. Heerschap and C. Figdor

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.59

    41. Iodinated agents; Tolerance—allergy

    42. CMR 2005: 11.05: Immunological mechanisms of delayed-type hypersensitivity reactions to iodinated contrast media (pages 81–82)

      M. Lerch, M. Keller, M. Britschgi, G. Kanny, V. Tâche, D. Schmid, B.O. Gerber, A.J. Bircher, C. Christiansen and W.J. Pichler

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.64

    43. CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity (page 82)

      K. Brockow, C. Christiansen, W. Aberer, A. Barbaud, A. Bircher, G. Kanny, W.J. Pichler, J. Ring, A. Romano and I. Szantho von Radnoth

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.65

    44. Molecular imaging; Small animal—phage display gene expression

      CMR 2005: 12.01: High-resolution x-ray microtomography of spleen in living mice (pages 82–83)

      M. Almajdub, L. Magnier, E. Chereul and M. Janier

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.66

    45. CMR 2005: 12.04: Stealthy magnetophages, a new tool for molecular imaging (page 84)

      J. Segers, C. Laumonier, S. Laurent, L. Vander Elst and R. N. Muller

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.69

    46. CMR 2005: 12.05: Use of in vivo imaging to follow siRNA-mediated reporter gene inhibition in a transgenic mouse skin model (page 85)

      Q. Wang, C.H. Contag, H. Ilves, Y.-A. Cao, B.H. Johnston and R.L. Kaspar

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.70

    47. CMR 2005: 12.06: Ultra-small iron oxide nanoparticle (USPIO)-labeled baculoviruses as novel MRI agents for imaging viral vector biodistribution in vivo (page 85)

      J. Hakumäki, J. Räty, T. Wirth, T. Huhtala, T. Ihalainen, M. Vihinen-Ranta, A. Närvänen and S. Ylä-Herttuala

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.71

    48. MRI; New agents—chemistry—relaxation

    49. CMR 2005: 13.02: Doubly luminescent gadolinium oxide nanoparticles as contrast agents for MRI (pages 86–87)

      J.-L. Bridot, C. Louis, S. Roux, C. Marquette, C. Billotey, O. Beuf, P. Perriat and O. Tillement

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.74

    50. CMR 2005: 13.03: Relaxivity of gadopentetate dimeglumine, gadobutrol and gadobenate dimeglumine in human blood plasma at 0.2, 1.5 and 3 T (page 87)

      F. Schick, J. Pintaske, P. Martirosian, H. Graf, G. Erb, K-P. Lodemann and C.D. Claussen

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.75

    51. CMR 2005: 13.04: Design and pharmacomodulation of high-relaxivity MR contrast agents (pages 87–88)

      M. Port, C. Corot, O. Rousseaux, I. Raynal and P. Bourrinet

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.76

    52. CMR 2005: 13.06: Activatable MRI CEST agents that detect enzyme activities (pages 88–89)

      M.D. Pagel, B. Yoo, G. Liu and R. Rosenblum

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.78

    53. CMR 2005: 13.07: Novel applications in the field of MRI CEST agents (page 89)

      S. Aime, D. Delli Castelli, E. Terreno and F. Uggeri

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.79

    54. MRI; Manganese—Hyerpolarized gas

      CMR 2005: 14.01: In vivo structural and functional imaging of the mouse spinal cord using manganese-enhanced MRI (pages 89–90)

      B. Stieltjes, S. Klussmann, A. Martin-Villalba, M. Bock and M. Essig

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.80

    55. CMR 2005: 14.02: Abdominal MRI made easy with orally administered manganese: a liver-specific contrast agent and a bowel marker (page 90)

      P. Leander, P. Höglund, K. Golman, G. Pettersson and S. Månsson

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.81

    56. CMR 2005: 14.03: Preliminary clinical experience with oral manganese (CMC-001) for liver imaging in daily routine (page 90)

      H.S. Thomsen, E. Chabanova, J. Moller, P. Leth, H. Dekker, J. Barentsz and V. Loegager

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.82

    57. CMR 2005: 14.04: Oral manganese as contrast medium in detecting liver metastases with MR imaging at 1.5 and 3 T (pages 90–91)

      H. Dekker, C. van Herpen, Y. Hoogeveen, H. Thomsen, T. Ruers and J. Barentsz

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.83

    58. CMR 2005: 14.05: First use of intra-articular carbon dioxide for MR arthrography; a feasibility study (page 91)

      R.M. Maes, J.S. Lewin, J.L. Duerk, C.J.M. Kiewiet and F.K. Wacker

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.84

    59. CMR 2005: 14.07: Investigation of ozone exposure effects on rat pulmonary function using hyperpolarized helium-3 (page 92)

      Y. Crémillieux, Y. Berthezène, S. Servais, D. Dupuich, A. Boussouar, V. Stupar and J.-M. Péquignot

      Version of Record online: 19 APR 2006 | DOI: 10.1002/cmmi.86

  1. Current Awareness

    1. Top of page
    2. Current Awareness

SEARCH

SEARCH BY CITATION